Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SIDT1 antisense RNA 1 (SIDT1-AS1) is a long non-coding RNA (lncRNA) transcribed from the antisense strand of the SIDT1 gene. It does not encode a protein but may regulate the expression of the neighboring SIDT1 gene or other molecular targets at the transcriptional or post-transcriptional level. Long non-coding RNAs such as SIDT1-AS1 are frequently studied for their roles in regulating gene expression, involvement in disease processes like cancer, and potential as prognostic or therapeutic biomarkers. To date, there is no evidence that SIDT1-AS1 itself constitutes a canonical therapeutic target such as a receptor, enzyme, transporter, or similar molecule[5]. Key distinctions: - **SIDT1-AS1** is not a protein, receptor, or conventional drug target; it is a non-coding RNA gene[5]. - **SIDT1** (not SIDT1-AS1) encodes a membrane protein involved in RNA and possibly cholesterol transport[6][1][3][4]. No evidence suggests misspelling or major ambiguity for "SIDT1-AS1," and available databases recognize this as a distinct non-coding RNA locus[5]. All major target-related lists (receptors, enzymes, etc.) do not include SIDT1-AS1 as a direct therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SIDT1 antisense RNA 1 (SIDT1-AS1).